GSK extends Avalon early-stage drug partnership

Screen Shot 2015-11-12 at 3.30.13 PM

By Denise Roland MarketWatch LONDON– GlaxoSmithKline PLC has extended a partnership with California venture-capital group Avalon Ventures that gives the drug maker rights to promising early-stage drug candidates. The U.K.-based pharmaceutical giant has increased the maximum amount of money it would…  Read More


Developers get immediate access to the Indix Product Intelligence Platform to strengthen existing commerce solutions and online shopping experiences SEATTLE — November 3, 2015 — Indix, the cloud-based Product Intelligence company that provides analytics and insights for brands, retailers and commerce…  Read More

TV Remains a Critical Advertising Platform, Says Report by Forbes Insights and Simulmedia – See more at:

NEW YORK, November 2, 2015—According to a new report by Forbes Insights, in association with Simulmedia, “Not Your Father’s Television: How Advertising Retains Value in the Digital Era,” television remains a critical advertising platform, despite the fragmenting media market. In…  Read More

Nanigans Extends Its Advertising Automation Software to Instagram


Written by: Cheryl Morris, VP Marketing  BOSTON, MASS. – (BUSINESS WIRE) – Nanigans, Inc., the leading worldwide provider of digital and mobile advertising software and pioneer in advertising automation, is extending its software to Instagram. Nanigans’ mission is to arm marketing teams…  Read More

Avalon, GSK found 3 more San Diego biotechs

Screen Shot 2015-06-16 at 2.55.31 PM

Total formed under alliance reaches 6 By Bradley J Fikes San Diego Union-Tribune Crossing the halfway point in their alliance to form up to 10 biotech companies in San Diego, La Jolla’s Avalon Ventures and UK-based GlaxoSmithKline said Monday they have added three…  Read More

Avalon Ventures and GSK Launch Three New Companies with Series A Financing and R&D Support as Part of Ongoing Successful Collaboration

Companies Include Adrenergics Developing Therapeutics for Dilated Cardiomyopathy; CadheRx Therapeutics Developing Therapeutic Antibodies for Oncology; and Calporta Therapeutics Developing Treatments for Diseases Associated with Dysregulated Lysosomal Function Media Contact: Heidi Chokeir, Ph.D. Canale Communications 619-203-5391 SAN DIEGO, June 15,…  Read More

Why Uber’s $50 Billion Valuation Could Burst the Tech Bubble


If Uber “got a cold, I think the rest of the ‘unicorns’ would get pneumonia,” venture capitalist Kevin Kinsella says. BY MARIA ASPAN  Senior editor, Inc.@mariaaspan Veteran venture capitalist Kevin Kinsella has a message for fast-growing startups: Take the money and…  Read More

5 Things to Remember in the Changing Landscape of VC

Here’s a set of important insights to keep in mind about today’s venture capitalists and their investing strategies. Inc. By Brady Bohrmann, Managing Director, Avalon Ventures The VC landscape has changed more in the past three years than in my…  Read More

Skycatch Mapping Team Assists Humanitarian Efforts in Nepal

Screen Shot 2015-04-29 at 4.37.04 PM

To get involved, contact See ongoing footage of relief efforts in Nepal Working in conjunction with UNESCO World Heritage and other organizations, Skycatch has deployed a UAV mapping team to Nepal. This team will use Skycatch’s drone hardware and data processing platform…  Read More